Recruiting NA INTERVENTIONAL 3-arm NCT06759116

Comparison Between Fentanyl and Dexmedetomidine As Adjuvant to Bupivacaine in Combined IPACK and Adductor Canal Block for Postoperative Analgesia After Knee Surgeries

Analgesic Effect of Fentanyl Vs Dexmedetomidine As Adjuvant to Bupivacaine in Combined IPACK and Adductor Canal Block After Knee Surgeries

Sponsor: Zagazig University

Conditions Analgesia, Postoperative

Interventions Control group Dexmedetomidine group Fentanyl group

Updated 2 times since 2025 Last updated: Jan 12, 2025 Started: Jan 10, 2025 Primary completion: Jul 10, 2025 Completion: Aug 10, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06759116, this NA trial focuses on Analgesia, Postoperative and remains actively recruiting participants. Sponsored by Zagazig University, it has been updated 2 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

2 versions recorded

Sep 2025 — Present [monthly]

Recruiting NA
Feb 2025 — Sep 2025 [monthly]

Recruiting NA

First recorded

Jan 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zagazig University

Data source: Zagazig University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• El Sharkia, Egypt